Apollo Hospitals Enterprise Ltd.'s consolidated net profit jumped 59% in the second quarter of the current financial year, beating analysts' estimates.
The company posted a profit of Rs 395.7 crore in the quarter ended Sept. 30, according to an exchange filing on Wednesday. Analysts tracked by Bloomberg had estimated a profit of Rs 367 crore.
Apollo Q2 FY25 Earnings Highlights (Consolidated, YoY)
Revenue up 15% to Rs 5,589.3 crore (Bloomberg estimate: Rs 5,532 crore).
Ebitda up 30% to Rs 815.5 crore (Estimate: Rs 781 crore).
Ebitda margin expands 170 basis points to 14.6% versus 12.9% (Estimate: 14.1%).
Net profit up 59% to Rs 395.7 crore (Bloomberg estimate: Rs 367 crore).
Healthcare services posted a revenue of Rs 2,903 crore, up 14% from Rs 2,547.2 crore. Earnings before interest, taxes, depreciation and amortisation grew 14% to Rs 722 crore, with the margin at 24.87%. Profit rose 16% to Rs 364.3 crore.
As of Sept. 30, Apollo Hospitals operated 7,994 beds across its network, excluding Apollo Health and Lifestyle Ltd. and managed beds, with an overall occupancy rate rising to 73% from 68%, supported by increased patient flows.
AHLL reported a revenue of Rs 403.9 crore, up 14%. The Ebitda grew 30% to Rs 41.4 crore, with the margin reaching 10.26%. Loss reduced to Rs 4.6 crore from Rs 13 crore.
Apollo HealthCo's revenue rose 17% to Rs 2,282 crore. It posted an Ebitda of Rs. 52.1 crore as compared to a loss of Rs 38.7 crore in the year-ago period, with the margin at 2.28%. Profit stood at Rs 19 crore as compared to a loss of Rs 67.8 crore. Apollo opened 154 new stores this quarter, bringing the total to 6,228. The gross merchandise value for Apollo 24/7 was Rs 756.9 crore, a 2% growth.
The company plans to establish a 500-bed hospital in Worli, Mumbai, through a build, operate and manage agreement. Its subsidiary aims to expand the current hospital facility in Lucknow from 300 to 500 beds by adding 200 more beds.
The total estimated project cost for these initiatives is around Rs 6,100 crore, out of which over Rs 1,700 crore has already been allocated for land acquisition, security deposits and project development. The remaining Rs 4,400 crore is expected to be spent over the next three–four years, primarily funded through existing funds and internal accruals.
Shares of Apollo Hospitals closed 0.02% lower at Rs 6,969.85 apiece on the BSE, compared to a 1.13% advance in the benchmark Sensex.